Zealand Pharma to accelerate drug development for obesity, metabolic disease

Zealand Pharma A/S

11/12/2025 06:17

LONDON, Dec 11 (Reuters) - Danish biotech company Zealand Pharma ZELA.CO said on Thursday it will accelerate development and expand its research as it seeks to differentiate its experimental obesity drug candidates in an increasingly competitive race to treat metabolic health issues.

 (Reporting by Maggie Fick and Terje Solsvik, editing by Essi Lehto)

 ((maggie.fick@thomsonreuters.com; +44 7890 916706;))